AI & Enterprise
Hecto Group joins state project to develop AI medical devices for early lung cancer detection
Hecto Group is developing AI medical devices to help detect lung cancer early and predict recurrence through a state-backed digital healthcare project. Its HAI unit joined the OnKoTECT consortium led by Seoul National University Bundang Hospital under the Ministry of Trade, Industry and Energy\'s Bio Industry Technology Development programme. The consortium will receive 15.5 billion won in research funding through December 2030 to develop and commercialise AI for early diagnosis and recurrence prediction of pancreatic and lung cancers.
